Radioembolization Oncology Trial Utilizing Transarterial Eye90 (ROUTE 90) for the Treatment of Hepatocellular Carcinoma (HCC)

The purpose of this study is to evaluate the safety and effectiveness of a new medical device and how well it works for people with HCC. The new medical device is called Eye90 microspheres (Eye90). This study is being done to add to what we know from a previous study conducted with 6 subjects in New Zealand about the safety and potential benefits of Eye90. This study is the second study to evaluate the use of this study device in humans